Gastroenteropancreatic Neuroendocrine Tumor G3
1 clinical trials · Condition
◉ Watch Gastroenteropancreatic Neuroendocrine Tumor G3
| Record | Firm | Date |
|---|---|---|
| A Study of Anlotinib in Patients With Gastroenteropancreatic Neuroendocrine Tumor G3 (NCT03457844) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2018-01-30 |
Track Gastroenteropancreatic Neuroendocrine Tumor G3 automatically
Every clearance here is in the API, with alerts when new ones post.